Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China
· Delayed Price · Currency is CNY 33.22
-1.19 (-3.46%)
Feb 28, 2025, 2:45 PM CST
SHE:002653 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 27, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 36,949 | 25,545 | 23,695 | 21,747 | 18,638 | 21,777 | Upgrade
|
| Market Cap Growth | 59.17% | 7.81% | 8.96% | 16.68% | -14.41% | 71.24% | Upgrade
|
| Enterprise Value | 37,725 | 26,256 | 25,227 | 22,521 | 19,066 | 22,271 | Upgrade
|
| Last Close Price | 33.31 | 22.80 | 21.91 | 19.86 | 16.82 | 19.47 | Upgrade
|
| PE Ratio | 77.10 | 86.56 | 85.52 | 63.02 | 29.28 | 44.09 | Upgrade
|
| Forward PE | 58.31 | 60.57 | 69.53 | 62.77 | 23.76 | 44.73 | Upgrade
|
| PS Ratio | 9.86 | 7.61 | 7.86 | 7.84 | 5.60 | 5.53 | Upgrade
|
| PB Ratio | 9.02 | 6.13 | 7.56 | 7.45 | 6.53 | 9.16 | Upgrade
|
| P/TBV Ratio | 13.91 | 7.45 | 10.18 | 10.07 | 8.10 | 10.62 | Upgrade
|
| P/FCF Ratio | 381.68 | 436.15 | - | - | - | 119.93 | Upgrade
|
| P/OCF Ratio | 79.51 | 56.82 | 250.62 | 607.43 | 90.39 | 28.49 | Upgrade
|
| EV/Sales Ratio | 10.13 | 7.83 | 8.37 | 8.12 | 5.73 | 5.66 | Upgrade
|
| EV/EBITDA Ratio | 60.63 | 52.01 | 79.50 | 122.44 | 57.27 | 54.20 | Upgrade
|
| EV/EBIT Ratio | 99.27 | 89.00 | 178.20 | 598.98 | 83.50 | 68.95 | Upgrade
|
| EV/FCF Ratio | 389.69 | 448.29 | - | - | - | 122.65 | Upgrade
|
| Debt / Equity Ratio | 0.50 | 0.43 | 0.67 | 0.43 | 0.38 | 0.45 | Upgrade
|
| Debt / EBITDA Ratio | 3.33 | 3.53 | 6.48 | 6.55 | 3.23 | 2.63 | Upgrade
|
| Debt / FCF Ratio | 21.42 | 30.84 | - | - | - | 5.95 | Upgrade
|
| Asset Turnover | 0.57 | 0.53 | 0.55 | 0.55 | 0.66 | 0.84 | Upgrade
|
| Inventory Turnover | 3.50 | 3.10 | 3.05 | 3.91 | 5.17 | 7.98 | Upgrade
|
| Quick Ratio | 1.72 | 1.50 | 1.09 | 0.81 | 1.04 | 0.73 | Upgrade
|
| Current Ratio | 1.99 | 1.76 | 1.38 | 1.02 | 1.22 | 0.83 | Upgrade
|
| Return on Equity (ROE) | 13.22% | 8.09% | 12.94% | 17.93% | 22.98% | 21.73% | Upgrade
|
| Return on Assets (ROA) | 3.62% | 2.90% | 1.60% | 0.47% | 2.85% | 4.29% | Upgrade
|
| Return on Capital (ROIC) | 3.98% | 3.29% | 1.88% | 0.58% | 3.86% | 6.32% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.96% | 5.73% | 3.11% | 1.08% | 6.96% | 12.72% | Upgrade
|
| Earnings Yield | 1.29% | 1.16% | 1.17% | 1.59% | 3.42% | 2.27% | Upgrade
|
| FCF Yield | 0.26% | 0.23% | -2.56% | -3.07% | -2.12% | 0.83% | Upgrade
|
| Dividend Yield | 0.78% | 0.88% | - | 0.93% | 2.21% | 0.47% | Upgrade
|
| Payout Ratio | 88.72% | 14.43% | 89.32% | 123.52% | 20.54% | 48.35% | Upgrade
|
| Buyback Yield / Dilution | -1.13% | -2.57% | 1.17% | 0.07% | -0.50% | 0.12% | Upgrade
|
| Total Shareholder Return | -0.35% | -1.69% | 1.17% | 1.00% | 1.71% | 0.59% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.